No one should face hereditary cancer alone.

Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.

Hereditary Cancer Info > Cancer Treatment > Ovarian Cancer Treatment

Toggle Menu

Ovarian Cancer Treatment

There are many options for treating hereditary cancers. Choice of treatment can be personalized based on cancer type, stage and genetics.

Related Force Information

Ovarian Cancer 101 for the Newly Diagnosed
Did you know that 20% of ovarian cancers can be attributed to an inherited genetic risk? Anyone diagnosed with ovarian or fallopian tube cancer should seek genetic counseling to determine if genetic testing is appropriate.Regardless of an inherited risk, it’s important to understand your diagnosis and the surrounding issues. Join gynecologic oncologist Ilana Cass, MD as she explains critical topics that every newly-diagnosed woman with ovarian cancer should know — including staging, standard-of-care, targeted therapies, participation in clinical trials, the latest research, and more.

Know More: Ovarian Cancer
Every woman with ovarian cancer meets national guidelines for genetic evaluation. Genetic information can affect treatment and improve outcomes for women with ovarian cancer and their relatives. Know More brings together FORCE resources on new targeted treatments, finding a genetics expert, and signing up for personalized support.

Other Websites

NCCN Guidelines for Patients: Ovarian Cancer
Patient version of the National Comprehensive Cancer Network Guidelines for ovarian cancer treatment.

Store My Tumor
StoreMyTumor is a company that offers tumor banking services. You can decide before surgery to preserve your tumor tissue to enable participation in breakthrough, personalized treatments including immunotherapy.

Information on Lynparza
Website from manufacturers of Lynparza, a PARP inhibitor that is the first targeted therapy approved for treatment of recurrent ovarian cancer in women with a BRCA mutation.

FORCE:Facing Our Risk of Cancer Empowered